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Introduction
Developmental dyslexia is a neurodevelopmental learning disability which has been estimated to affect 5-10% of UK children 1 . It is characterised by unexpectedly poor reading relative to the child's general intelligence, not explained by other factors such as socio-economic background or gross neurological deficit. Developmental dyslexia is known to have a considerable genetic component 2-4 , but the mechanisms which give rise to the condition remain unclear. However, it seems increasingly clear that dyslexia is a neurobiological syndrome characterised by both structural 5 and functional 6 brain differences.
Abnormalities of phospholipid metabolism may play an important role in neurodevelopmental disorders such as schizophrenia 7 , autism 8 and also dyslexia 9,10 . Phospholipids are the basis of cell membranes; in the brain the type of phospholipid present in neuronal membranes can affect neuronal function 11,12 . Evidence that phospholipid metabolism may be relevant to dyslexia includes abnormal phospholipid metabolism in dyslexics in vivo 13 , significantly more clinical signs of fatty acid deficiency in dyslexics than controls 14 and overactivity in dyslexics of the enzyme phospholipase A2, which is involved in the remodelling of phospholipid membranes 15 . Extending this hypothesis, we recently proposed that levels of the phospholipid platelet-activating factor (PAF) could be raised in dyslexia 16 , and that this could account for some of the differences seen in dyslexic individuals' brains. PAF is a neuroimmune mediator with multiple functions, Given that dyslexia is a syndrome with a biological basis, it is likely to interact with other biological syndromes, and the pattern of these interactions may provide clues to the underlying aetiology. The PAF hypothesis makes certain predictions about the association of dyslexia with some common clinical conditions. In particular, PAF is a potent vasodilator which is known to lower blood pressure in a rat model, an effect which can be prevented by pre-administration of the PAF-inactivating enzyme and parents' grandparent (N = 1).
Classification of individuals: Individuals were classified as dyslexic if their BAS
Reading was at least 10 T-score points (1 standard deviation) below their BAS Similarities, or if they had an educational psychologist's report stating that they were dyslexic. Most individuals in our sample fell into this category.
Individuals were classified as control if they did not meet the above dyslexic criteria.
There were 12 individuals in this category. Some of the 90 families in our study have one child participating, others more than one. However, since the families were selected for dyslexia in the children, including families with only one child could distort the analysis; since controls are concentrated in the multiple-child families, family size is a potential confound 1 . A better comparison is to take families with more than one child (N = 27), and look at the history of HBP in families where all the children were dyslexic ("all-dyslexic": N = 16) with families where not all children were not dyslexic ("part-dyslexic": N = 11).
We predicted that "part-dyslexic" families would be more likely than "all-dyslexic" families to have a history of HBP. Fisher's exact test was used to test this prediction. Since the number of controls was small, and since they were from families at risk of dyslexia rather than from the general population, they could have had dyslexic tendencies or other characteristics which could distort the results. We therefore restricted the analysis to dyslexics only. To take account of family size, the unit of analysis was taken to be the family, and mean psychometric values were calculated for each family (dyslexic children only Familial analysis for families with multiple children: Of the 16 "all-dyslexic" families, 7 were HBP+ and 9 were HBP-. Of the 11 "part-dyslexic" families, all 11 were HBP+.
The distribution of familial HBP differed significantly between these two groups (Fisher's exact test: 2-sided significance level p = 0.003).
T-test: To account for family structure, we compared mean psychometric scores of (dyslexic only) children in HBP+ (N = 38) and HBP-(N = 52) families using a t-test.
Statistically significant differences between HBP+ and HBP-families were seen for BAS Recall of Digits, Reading and Spelling. Scores were significantly higher for the HBP+ group than the HBP-group. Similarities (verbal reasoning) showed the same 9 pattern, though not to the same extent as Recall of Digits (working memory) and
Reading. In short, a family history of HBP was associated with better performance on tests which dyslexics find comparatively difficult. Table 1 shows the mean psychometric scores for the HBP+ and HBP-family groups (SD = standard deviation, SE = standard error of the mean).
[ Table 1 near here]
Discussion
We have proposed the hypothesis that the phospholipid platelet-activating factor (PAF) may play a role in developmental dyslexia 16 . This hypothesis predicts a negative association between dyslexia and high blood pressure (HBP). Results of our pilot study indicate clear differences, in the direction predicted by the hypothesis, between children at risk for dyslexia with and without a family history of HBP. Even when only the dyslexic individuals in our sample were analysed, our results indicate that children from families with a history of HBP perform significantly better on psychometric tests of reading and spelling.
Sources of bias: Any study such as this which uses self-report data from a questionnaire is open to problems. A common criticism is that some individuals may be more willing to report clinical conditions than others. In this case, individuals who themselves have a disorder may be more willing to report their clinical history; and women may be more willing to report than men. This form of bias can never be ruled out altogether in a questionnaire study. However, it is worth noting that:
1) At the time of the study, respondents to the questionnaires could not have been aware of the hypothesis specifically tested here, since it had not been published.
Both parents in families with one or more dyslexic children were asked about a large number of clinical conditions. The aim of the study was to assess immune dysfunction, the prevalence of which is controversial in developmental dyslexia 25-29 . 2) Since all families were taken from a cohort already investigated for dyslexia, there was unlikely to be a bias on the basis of dyslexic status.
3) A Fisher's exact test (data not shown for reasons of space) indicated no statistically significant difference between male and female response rates to the questionnaire.
4) HBP+ and HBP-groups did not differ significantly on age, sex and general ability, reducing the likelihood of bias due to these factors. Moreover, the families have a similar socio-economic background and come from the same geographic area (Central Southern England).
A potential source of bias which cannot be ruled out is that of non-response bias --whether the families not asked about their clinical history differed from those who were asked with respect to the relevant variables. Given the total lack of awareness of the hypothesis among the families, it is difficult to see what this difference could be.
However, we hope to address this problem, and the problem of self-report bias, in a study currently being planned which will not use questionnaire data.
Finally, given the small numbers, and the fact that the sample from which control subjects were taken was a sample at risk for dyslexia, it is likely that the controls themselves have dyslexic tendencies. However, this should tend to decrease the likelihood of observing a statistically significant association between dyslexic status and HBP. Moreover, even when controls were excluded from the analysis, children with and without a family history of HBP still showed significantly different performances on reading-related psychometric tasks. Families with a control child among the children were significantly more likely to have a history of high blood pressure than families where all the children were dyslexic.
To summarise, we believe that this study is consistent with the PAF hypothesis of dyslexia. To our knowledge, no other hypothesis of developmental dyslexia has made this particular prediction or has proposed mechanisms which could explain this finding. That is not to say that there are not other mechanisms which could explain the observed relationship between dyslexia and familial high blood pressure. PAF is part of an extremely complex network of cytokines whose effects on intracellular signalling systems have yet to be disentangled. However, the prediction, which was specifically generated by the PAF hypothesis, has been confirmed; we consider therefore that the hypothesis may continue to serve as a basis for research. Whatever the causative mechanisms, we hope our study will help to make the important point that dyslexia is more than just a cognitive difference.
The instrument used in our study was a simple questionnaire asking whether parents of dyslexic children, or any of their relatives, had ever suffered from a range of clinical conditions (including immune disorders, developmental disorders and numerous other conditions). Given the unrefined nature of this assessment and the small numbers in the groups, so clear a result was unexpected. It is possible however that the small numbers may have affected the results (although any such effect would arguably be likely to blur distinctions rather than enhance them). A study is currently being planned to see if the result can be replicated with larger numbers. In the meantime, we hope that since developmental dyslexia is now widely accepted as a brain-based physiological condition, epidemiological studies of its comorbidity with 13 other diseases could provide much-needed clues to the underlying mechanisms involved. 
